NeuroHelp

Develop creative neurotechnology for improving the health and quality of life of individuals with neurological conditions. While our present focus is epilepsy, our vision extends to assisting with a multitude of neurological disorders. Epilepsy is a chronic disease characterized by seizures of enhanced and synchronous electrical activity in neuronal networks in the brain, affecting 1% of the worlds population. Importantly, around 30% of the patients do not respond to current medications and their seizures cannot be predicted Our team developed novel data analysis and machine learning solutions that use non-invasive brain monitoring to forecast upcoming seizures an hour in advance....

Neurohelp operates in the Medical equipment manufacturing industry.

Neurohelp's revenue is 11m - 100m

Neurohelp has 11 - 50 employees.